BODI saw its Momentum Indicator move below the 0 level on November 11, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned negative. In 89 of the 97 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for BODI turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 44 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BODI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for BODI entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where BODI advanced for three days, in 197 of 234 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
BODI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 24 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.832) is normal, around the industry mean (0.974). P/E Ratio (2.388) is within average values for comparable stocks, (-39.046). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (17.274). Dividend Yield (0.000) settles around the average of (0.979) among similar stocks. P/S Ratio (0.167) is also within normal values, averaging (71.888).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. BODI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BODI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The RSI Oscillator for META moved into overbought territory on November 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +5.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where META advanced for three days, in 239 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
META may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on META as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for META turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 34 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
META moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for META crossed bearishly below the 50-day moving average on October 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where META declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
The Aroon Indicator for META entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. META’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.950) is normal, around the industry mean (0.974). P/E Ratio (22.682) is within average values for comparable stocks, (-39.046). Projected Growth (PEG Ratio) (0.947) is also within normal values, averaging (17.274). Dividend Yield (0.003) settles around the average of (0.979) among similar stocks. P/S Ratio (7.570) is also within normal values, averaging (71.888).
BODI | META | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 45 Fair valued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 43 | |
SMR RATING 1..100 | 24 | 33 | |
PRICE GROWTH RATING 1..100 | 91 | 59 | |
P/E GROWTH RATING 1..100 | 97 | 66 | |
SEASONALITY SCORE 1..100 | 50 | 30 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BODI's Valuation (45) in the null industry is in the same range as META (74) in the Internet Software Or Services industry. This means that BODI’s stock grew similarly to META’s over the last 12 months.
META's Profit vs Risk Rating (43) in the Internet Software Or Services industry is somewhat better than the same rating for BODI (100) in the null industry. This means that META’s stock grew somewhat faster than BODI’s over the last 12 months.
BODI's SMR Rating (24) in the null industry is in the same range as META (33) in the Internet Software Or Services industry. This means that BODI’s stock grew similarly to META’s over the last 12 months.
META's Price Growth Rating (59) in the Internet Software Or Services industry is in the same range as BODI (91) in the null industry. This means that META’s stock grew similarly to BODI’s over the last 12 months.
META's P/E Growth Rating (66) in the Internet Software Or Services industry is in the same range as BODI (97) in the null industry. This means that META’s stock grew similarly to BODI’s over the last 12 months.
| BODI | META | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 85% | 3 days ago 84% |
| Stochastic ODDS (%) | 3 days ago 85% | 3 days ago 74% |
| Momentum ODDS (%) | 3 days ago 90% | 3 days ago 71% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 67% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 65% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 69% |
| Advances ODDS (%) | 19 days ago 84% | 13 days ago 74% |
| Declines ODDS (%) | 5 days ago 90% | 3 days ago 59% |
| BollingerBands ODDS (%) | 3 days ago 75% | 3 days ago 82% |
| Aroon ODDS (%) | 3 days ago 89% | 3 days ago 81% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BODI’s FA Score shows that 1 FA rating(s) are green while META’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BODI’s TA Score shows that 4 TA indicator(s) are bullish while META’s TA Score has 4 bullish TA indicator(s).
BODI (@Internet Software/Services) experienced а -22.60% price change this week, while META (@Internet Software/Services) price change was -12.60% for the same time period.
The average weekly price growth across all stocks in the @Internet Software/Services industry was -12.86%. For the same industry, the average monthly price growth was -14.69%, and the average quarterly price growth was -22.54%.
BODI is expected to report earnings on Mar 16, 2027.
META is expected to report earnings on Feb 03, 2027.
Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.
A.I.dvisor tells us that BODI and UPWK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BODI and UPWK's prices will move in lockstep.
| Ticker / NAME | Correlation To BODI | 1D Price Change % | ||
|---|---|---|---|---|
| BODI | 100% | -6.43% | ||
| UPWK - BODI | 23% Poorly correlated | -2.40% | ||
| THRY - BODI | 22% Poorly correlated | +4.45% | ||
| ANGI - BODI | 22% Poorly correlated | -2.93% | ||
| BZ - BODI | 22% Poorly correlated | -1.98% | ||
| ZG - BODI | 21% Poorly correlated | N/A | ||
More | ||||